| Mary E Spare, NP-C | |
|
2114 Generals Hwy, Annapolis, MD 21401-7488 | |
| (888) 808-6483 | |
| Not Available |
| Full Name | Mary E Spare |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 2114 Generals Hwy, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154874220 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 0024173630 (Virginia) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | R099071 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Bariatric surgery-as a last resort when conservative interventions have failed-can improve liver disease and other obesity-related health problems in severely obese children and adolescents, according to a position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
All patients arriving at UCSF's Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.
Trovagene, Inc., a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays.
› Verified 4 days ago
| Entity Name | Harcart Health Holdings, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912911215 PECOS PAC ID: 7810097532 Enrollment ID: O20101013000400 |
News Archive
Bariatric surgery-as a last resort when conservative interventions have failed-can improve liver disease and other obesity-related health problems in severely obese children and adolescents, according to a position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
All patients arriving at UCSF's Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.
Trovagene, Inc., a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays.
› Verified 4 days ago
| Entity Name | Medstar Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902175870 PECOS PAC ID: 9335303155 Enrollment ID: O20120607000236 |
News Archive
Bariatric surgery-as a last resort when conservative interventions have failed-can improve liver disease and other obesity-related health problems in severely obese children and adolescents, according to a position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
All patients arriving at UCSF's Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.
Trovagene, Inc., a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays.
› Verified 4 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
Bariatric surgery-as a last resort when conservative interventions have failed-can improve liver disease and other obesity-related health problems in severely obese children and adolescents, according to a position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
All patients arriving at UCSF's Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.
Trovagene, Inc., a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary E Spare, NP-C 2209 Defense Hwy, Crofton, MD 21114-2403 Ph: (443) 332-4260 | Mary E Spare, NP-C 2114 Generals Hwy, Annapolis, MD 21401-7488 Ph: (888) 808-6483 |
News Archive
Bariatric surgery-as a last resort when conservative interventions have failed-can improve liver disease and other obesity-related health problems in severely obese children and adolescents, according to a position paper in the Journal of Pediatric Gastroenterology and Nutrition, official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.
All patients arriving at UCSF's Emergency Department with heart attack will continue to be treated with standard measures. Patients who meet the medical criteria for the trial will be able to elect to receive the stem cell therapy within seven days after their heart attack.
Trovagene, Inc., a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays.
› Verified 4 days ago
Brenda Kay Mathews-vitello, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 Defense Hwy, Suite 400, Annapolis, MD 21401 Phone: 410-897-9841 Fax: 410-897-9852 | |
Mrs. Jillian Lynn Preston, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 166 Defense Hwy Ste 101, Annapolis, MD 21401 Phone: 877-461-1564 | |
Alexa Lee St Laurent, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2024 West St Ste 400, Annapolis, MD 21401 Phone: 410-224-7667 Fax: 410-224-7007 | |
Dabney Lipscomb, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Wayson Pavilion, Suite 150, Annapolis, MD 21401 Phone: 443-481-1199 Fax: 443-481-1495 | |
Ms. Stephanie Zwonitzer, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1750 | |
Mrs. Hollis Stewart Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 678 Genessee St, Annapolis, MD 21401 Phone: 412-508-7896 | |
Lisa Kristine Butler, MSN, CRNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2002 Medical Pkwy Ste 670, Annapolis, MD 21401 Phone: 443-481-1150 |